# Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells

> **Open Intelligence Dossier** · First detected: 2026-07-02 00:07 UTC · Category: Health

## Executive Summary
New GPNMB‑CAR‑T therapy shows promise against the deadliest brain cancer, glioblastoma.

## Intelligence Brief
A dual tumour–myeloid targeting approach using GPNMB CAR‑T cells is being reported as a potential treatment for aggressive glioblastoma. The strategy combines CAR‑T cell engineering with cytokine armouring to attack both tumor cells and supporting immune cells.


Coverage highlights the therapy's promise to eliminate the aggressive brain tumor, noting its innovative immunotherapy design. Outlets including News‑Medical, Labmate‑Online, Medical Xpress, The Telegraph and Nature all emphasize the potential impact on the deadliest form of brain cancer.


Future reporting will need to clarify the stage of development, efficacy data and any clinical trial outcomes, as current coverage does not specify these details.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Oncodaily | Beeta Benjy: What is the Missing Puzzle Piece of CAR-T Therapy Failure in Solid Tumors? | [Source Link](https://news.google.com/rss/articles/CBMiW0FVX3lxTE02SlFpMGtSc1FSNEZOT3VIX0pNMmVqVW1BNWxmUm1CNV9NVzRiR2pmVE9fallmRkxBWi1ZZlE5LXZqSVZEM3RrMzJyd29nckZHRU1fM0RvQXNTd3c?oc=5) |
| Labroots | Engineered Immunotherapy Improves Treatment for Brain Cancer | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxQVms5bk1ERmVXLUp6dlVFZ0xSX0lCWW41VzZ4alJvSVY3ZV9lc19EbW5pYkJsb0pETXIzREUyNFE4TVRVbC13Rzgyd1BKZGdmT0JiU1hPTE51ZERDejZ4VWVYQ09UMFVrU3VJdU5EelFiNGhUVGsyeWhTN1hMU2MtbFhBV05LNzJyeDRIYUtjQldZY1FZNDVwN2lfdFJ6ZlJJVUVyTnA3RDBsNTDSAbABQVVfeXFMTUJ3cE5EazAwaFNXMjE4eTJ3TVAyaTZxN3gtc3JaVWJnaV8yc0d2dzVLdWRVQnRzNkdDYnhDbTZKQVRKaFAzTkpVZ1ZZUks5U2JkOTRrbnZTMExOSFVCU3lfQkNCV0puNFNzNEluSUJzamJ2YVI2NVN4SXJQZVdYQmE4bWhVcDhVYUNKM1dnclJYQ29WVVZ0ZjlFS0ZTTkJGTzRkQy1QVUw) |
| Inside Precision Medicine | CAR T Cells Simultaneously Target Glioblastoma and Immune Cells | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxNR3FLOGE1ZXIzYXFmSUotQzRPbkVGdHBmdU5rRF9jVmhyQXRFV05OWmJ0OWxLMVhJdWwtc0pva3RseTd3RXdQaGVyMWFBaE1JWnJMVXp2Y2E3YzFPb05UR1BvZTJrd3pBNmhXczdhUTZnckNid0FsRE4wTk5maUg5dDJfbWhuSFBsLWZ2bkIwbHZ2dlVYSEIyQ0hua0k3eWZEem1OczZCcW84dV9pVjRmMEhkbDVhVnJpR1NMeQ?oc=5) |
| Newsweek | New Therapy Could Target One of the Deadliest Brain Cancers | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQNFNOWnhWODdoV29VdVBDdzdiNmtEcXFtcmdFVll6aGlSZExNUXpXT0toV0F4eXFZbXNZU0U1X3dZd3Z4bWZRZ0FBU21hTHczM21sdzVraFl3M1VnS1NQQmdMR0xVN1pjT1BaVk9LN1RmU2x0YlozdFFJVGlHVDhPS1RqUk52ZHh4ZmVleE9BbnFJV0ZRNzBHUA?oc=5) |
| University of Calgary | Community giving powers a UCalgary cancer immunotherapy breakthrough | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQUTBLN0MtLW02NjZGSS1reWhNcnhocHVhOC1aOVJlbnZLVm1jS2lvc1VDM05CbW1GZWNpRVBiVkY1c1pvQkt0aDdHcE9zbTlYeXRpMS0tRjBpZ1BQUGx6dHBSOHhaLThJZG1jVm1rRDdjMWlNRnBDWVplb3o2RUppTXI0eF9RWGxUQ1Vwa19UMnhMX0tQOFBj?oc=5) |
| University of Calgary | New immunotherapy developed at the University of Calgary being used to treat solid cancerous tumours | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxQWkdxZGJqaUltV25LcDVhYjNlY0g1dkpLUG1KMDRnQl94MUtOOG50aE9RUTJ2eHlLbnRKTFd2Tzh3eVBBZTZWYUd6amcyVlR5WTFNbkVicE44UUJPSmdWVHBwZ1YzcG90WE5wQ2VjYmM2dm1VaGtWQUtvVGpEY09BdGxOcGdPVWZaMUQwQUY1VDZqdXFJMzIxSEN0eE9mR3lNS0QybEJ1SmRhcWlYZW9GWlJR?oc=5) |
| BioWorld News | With GPNMB, CAR T makes further inroads in solid tumors | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxNZ2Z1SUowaXZGNlRqdFlmZm9lOXN0QUt1cFNNNkx0OE96Ym9XS2ZmcTF4QWc0QnEtb3JGVHJDb2R5OGVxbU9tdnNrd1JSRmVEZUpoU3M4RUllTHBRS1lMMlFEUEtSZE9zMERVSU9sOWlseDZZSnlzMUdKNkQ3d3NNaTJGaVNiTXV0Yi1TcUxTSGNVRFFURG9ENExuUQ?oc=5) |
| Calgary Herald | U of C-developed experimental treatment reduces rare cancerous tumours | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxOMEtkaXFmVlNYckR3eDFsRUlnQXBSS2w2OUpOLVF4NTlOOExSVjk0V1EzTlluN2VPZUxNUDNOVUhqTncwTWpIRkd3ZVBSX2hlV3pSczJHQXQxSk5RZEt4bUdkTmg5Q3YtMElfRDdhMHgyYTdEeGYzcG1IbzhwNjFhUG5CcHNNbjJrWU5sZjVqTHc3WW9mMVV4cUlvak83Y2FzZU44TERic0pxNVZ4WWZtTVZ3?oc=5) |
| Northwestern University | Immunotherapy Strategy Shows Promise for Deadly Brain Cancer | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxQLU16S3F3UU5ldXotcjFEYUtXTDNJR1pTd3V1RVFKU1VYN2ZPQ09sdUMtaDhGYW1NS2JUNUFmU05Cd2RJMmE4X3VMSmt2QWVXdmdBaDBSUnF6OWFZSi1vT09rOUp0SlBtaDhqaFFvUnRIRlIzb2s0Z0JhUlZvZi1sV054a0syVWJiUmYxbG8yTkJVT3FWVnRIa2NMV2h6MVVGeFZDRXIyc0FsNzVQR3NqNg?oc=5) |
| Newswise | McMaster-Developed Immunotherapy Strategy Targets Aggressive Brain Tumours and Their Fuel - Newswise | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaUgyYk0zakIyMWRQM1hsRFI1R3hQbElLbmdfZEROQkxReExsNlRFY3ZycWNWOUZYVDVPUkt1T2FhT19WckYzOVlXMEJIZGU3UFozeG9uM21Rek8wT1hVUlJhXzNRcWNodXRfTHB3X3NCenJRSDkxSHI0bkdqZGs4aTU2VU9SRDV1c1BiaG9tMDBJSkVPbFR0cU4tdWY2UDljb1JiOFZMOFA1VDg5X1BNOGsyU1VwSU5DRzBHTEZ3TjHSAcABQVVfeXFMTmlIMmJNM2pCMjFkUDNYbERSNUd4UGxJS25nX2RETkJMUXhMbDZURWN2cnFjVjlGWFQ1T1JLdU9hYU9fVnJGMzlZVzBCSGRlN1BaM3hvbjNtUXpPME9YVVJSYV8zUXFjaHV0X0xwd19zQnpyUUg5MUhyNG5HamRrOGk1NlVPUkQ1dXNQYmhvbTAwSUp) |
| News-Medical | CAR-T cell therapy shows potential to eliminate aggressive glioblastoma | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxNdE9QMzZLNldNcy13cDh0RkhtM19VQXQwaUt6UlR3N2xyZUE2WDJvU01xTHd3SFpodDh0cXFWcjZmUnpaaTF0eDJTTEdGdmZoZ0MtVjhXdXVvMXFQWWxqTjl3YkpsNnFhRnVPQzV5ajYzcEtyTHBIaFhQVTF1VXlmZjE3UkFwM2sxSnRQUWpUSy1fQ1NIRmRYb3FSaFhvdXpQWXZBSTZNN2tfbTNmSm41UDI5Ql9BczBLYnZv?oc=5) |
| Labmate-Online | Cytokine-armoured CAR T therapy shows promise against aggressive glioblastoma | [Source Link](https://news.google.com/rss/articles/CBMi9AFBVV95cUxQa1ZNSkV4Y2ZYaWpYNUxQamFpclk1bm1KRTZ2aXlISy1aT01rYmJHR0l2YzRheHFpbEN1SDBKeDNiY2NwQWNvVnphUndPYm14d2hxMlRlVDZOTjhRR2lhUWNFNzNkMUZQWmNySVRGSUxtMW9QVWVfWUtZdjZMVEhtdGdOaGU0N082VXlTQ1dISllaWUFzSnczR3F1aVdhVTVZbEdKX2kzVTM0N2VEMnYwT0QzZ0FoSWlzbmwzbG1IYjV0aFVjQzRJSGpUVzc5eWlNOHp3MzZHa0l4R2NCUlU3SFpNT29Db0UwNUQ2Wm9YWkd6TDlC?oc=5) |
| Medical Xpress | New immunotherapy strategy targets aggressive brain tumors and their immune cell accomplices | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxNZTFRWFI0Ujg4QS1aSmUtMUtWb1BVMGhkeEFyRVVJZjg0MFFLTjJEckhPNm5hSnQ0T3cxT0VlWnFQRWtYUWRUcVRjLWpLM09aZVFvT2JNaEZobEF2a2hQR2ZvZHVHb3dqbW42NDRUX2poTTViQ19HWHpCR3JRSUJNZnQtX2Fhc2NSaHJWcnZLdkRjTnRh?oc=5) |
| The Telegraph | Deadliest brain cancer could be treated with immunotherapy | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxNUDhzdk16N2l6aGcwUmRZLVR1Uko0aS0xTEk4WENKM3V0d3E3WUN4UDZmTFMwS2twSWhEcHZWV1lLcHg1azFtcGMzVTI1R01ielpGYVYyLWhZM2pjRUpPcTgwWmNHZ25jMUlId3g2UnVpN1NoMUgwM0tBOEFMNmtGYWpMaFJoenFwc1VRcVY3RUo1TnNuM2l4NmUwd1YzNVdLTG9sMFdR?oc=5) |
| Nature | Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTFA2NmhWU0lFU255TGtVRGtpNmU2OF85a1VyVEZXMjVqNGVPSGtPazFqc3l1aUZ4ckFfckY1cHllZ25oWWNiOGlzZW94dkJCZDZMMWhHTFpkeW10RzdzVERr?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-02/dual-tumour-myeloid-targeting-of-glioblastoma-with-gpnmb-car-t-cells*